$85.67
9.35% yesterday
NYSE, Sep 03, 10:00 pm CET
ISIN
US4577301090
Symbol
INSP

Inspire Medical Systems, Inc. Target price 2025 - Analyst rating & recommendation

Inspire Medical Systems, Inc. Classifications & Recommendation:

Buy
58%
Hold
42%

Inspire Medical Systems, Inc. Price Target

Target Price $153.00
Price $85.60
Potential
Number of Estimates 19
19 Analysts have issued a price target Inspire Medical Systems, Inc. 2026 . The average Inspire Medical Systems, Inc. target price is $153.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 26 analysts: 15 Analysts recommend Inspire Medical Systems, Inc. to buy, 11 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Inspire Medical Systems, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Inspire Medical Systems, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 802.80 922.70
28.49% 14.94%
EBITDA Margin 5.31% 20.35%
188.64% 283.23%
Net Margin 6.67% 1.64%
296.91% 75.40%

21 Analysts have issued a sales forecast Inspire Medical Systems, Inc. 2025 . The average Inspire Medical Systems, Inc. sales estimate is

$923m
Unlock
. This is
7.13% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$953m 10.68%
Unlock
, the lowest is
$882m 2.40%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $803m 28.49%
2025
$923m 14.94%
Unlock
2026
$1.1b 14.34%
Unlock
2027
$1.2b 14.79%
Unlock
2028
$1.4b 15.85%
Unlock
2029
$1.6b 13.33%
Unlock
2030
$1.8b 15.28%
Unlock
2031
$1.8b 1.91%
Unlock

19 Analysts have issued an Inspire Medical Systems, Inc. EBITDA forecast 2025. The average Inspire Medical Systems, Inc. EBITDA estimate is

$188m
Unlock
. This is
259.74% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$217m 315.25%
Unlock
, the lowest is
$141m 170.78%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $42.6m 213.89%
2025
$188m 340.42%
Unlock
2026
$232m 23.33%
Unlock
2027
$268m 15.56%
Unlock
2028
$347m 29.65%
Unlock
2029
$439m 26.51%
Unlock
2030
$535m 21.90%
Unlock
2031
$519m 2.97%
Unlock

EBITDA Margin

2024 5.31% 188.64%
2025
20.35% 283.23%
Unlock
2026
21.95% 7.86%
Unlock
2027
22.09% 0.64%
Unlock
2028
24.73% 11.95%
Unlock
2029
27.60% 11.61%
Unlock
2030
29.19% 5.76%
Unlock
2031
28.87% 1.10%
Unlock

21 Inspire Medical Systems, Inc. Analysts have issued a net profit forecast 2025. The average Inspire Medical Systems, Inc. net profit estimate is

$15.1m
Unlock
. This is
71.55% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$33.2m 37.46%
Unlock
, the lowest is
$11.3m 78.73%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $53.5m 353.00%
2025
$15.1m 71.76%
Unlock
2026
$46.2m 205.49%
Unlock
2027
$77.8m 68.52%
Unlock
2028
$119m 53.25%
Unlock
2029
$165m 38.82%
Unlock
2030
$221m 33.32%
Unlock
2031
$200m 9.23%
Unlock

Net Margin

2024 6.67% 296.91%
2025
1.64% 75.40%
Unlock
2026
4.38% 167.07%
Unlock
2027
6.42% 46.58%
Unlock
2028
8.50% 32.40%
Unlock
2029
10.41% 22.47%
Unlock
2030
12.04% 15.66%
Unlock
2031
11.14% 7.48%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 1.75 0.51
343.06% 70.86%
P/E 167.54
EV/Sales 2.42

21 Analysts have issued a Inspire Medical Systems, Inc. forecast for earnings per share. The average Inspire Medical Systems, Inc. EPS is

$0.51
Unlock
. This is
71.67% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.12 37.78%
Unlock
, the lowest is
$0.38 78.89%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $1.75 343.06%
2025
$0.51 70.86%
Unlock
2026
$1.56 205.88%
Unlock
2027
$2.63 68.59%
Unlock
2028
$4.03 53.23%
Unlock
2029
$5.60 38.96%
Unlock
2030
$7.46 33.21%
Unlock
2031
$6.77 9.25%
Unlock

P/E ratio

Current 47.56 94.98%
2025
167.54 252.30%
Unlock
2026
54.83 67.27%
Unlock
2027
32.54 40.65%
Unlock
2028
21.23 34.76%
Unlock
2029
15.30 27.93%
Unlock
2030
11.47 25.03%
Unlock
2031
12.64 10.20%
Unlock

Based on analysts' sales estimates for 2025, the Inspire Medical Systems, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.59 62.89%
2025
2.42 6.66%
Unlock
2026
2.11 12.54%
Unlock
2027
1.84 12.88%
Unlock
2028
1.59 13.69%
Unlock
2029
1.40 11.76%
Unlock
2030
1.22 13.26%
Unlock
2031
1.24 1.95%
Unlock

P/S ratio

Current 2.94 61.32%
2025
2.74 6.65%
Unlock
2026
2.40 12.54%
Unlock
2027
2.09 12.88%
Unlock
2028
1.80 13.69%
Unlock
2029
1.59 11.76%
Unlock
2030
1.38 13.26%
Unlock
2031
1.41 1.95%
Unlock

Current Inspire Medical Systems, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Leerink Partners
Locked
Locked
Locked Aug 15 2025
Keybanc
Locked
Locked
Locked Aug 05 2025
Wells Fargo
Locked
Locked
Locked Aug 05 2025
Piper Sandler
Locked
Locked
Locked Aug 05 2025
RBC Capital
Locked
Locked
Locked Aug 05 2025
JP Morgan
Locked
Locked
Locked Aug 05 2025
Lake Street
Locked
Locked
Locked Aug 05 2025
Analyst Rating Date
Locked
Leerink Partners:
Locked
Locked
Aug 15 2025
Locked
Keybanc:
Locked
Locked
Aug 05 2025
Locked
Wells Fargo:
Locked
Locked
Aug 05 2025
Locked
Piper Sandler:
Locked
Locked
Aug 05 2025
Locked
RBC Capital:
Locked
Locked
Aug 05 2025
Locked
JP Morgan:
Locked
Locked
Aug 05 2025
Locked
Lake Street:
Locked
Locked
Aug 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today